Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

Similar articles for PubMed (Select 23754278)

1.

The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.

Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra DS, Qian Z, Rana A, Kanthasamy AG.

J Biol Chem. 2013 Jul 26;288(30):21955-71. doi: 10.1074/jbc.M112.444224. Epub 2013 Jun 10.

2.

Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.

Kanagaraj N, Beiping H, Dheen ST, Tay SS.

Neuroscience. 2014 Jul 11;272:167-79. doi: 10.1016/j.neuroscience.2014.04.039. Epub 2014 Apr 30.

PMID:
24792712
3.

The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Ding YX, Xia Y, Jiao XY, Duan L, Yu J, Wang X, Chen LW.

Neurochem Res. 2011 Oct;36(10):1759-66. doi: 10.1007/s11064-011-0491-5. Epub 2011 May 12.

PMID:
21562748
4.

PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.

Lee YP, Kim DW, Kang HW, Hwang JH, Jeong HJ, Sohn EJ, Kim MJ, Ahn EH, Shin MJ, Kim DS, Kang TC, Kwon OS, Cho SW, Park J, Eum WS, Choi SY.

FEBS J. 2012 Jun;279(11):1929-42. doi: 10.1111/j.1742-4658.2012.08574.x. Epub 2012 Apr 16.

PMID:
22429328
5.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
6.

Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.

Yao L, Li W, She H, Dou J, Jia L, He Y, Yang Q, Zhu J, Cápiro NL, Walker DI, Pennell KD, Pang Y, Liu Y, Han Y, Mao Z.

J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13.

7.

Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice.

Steidinger TU, Slone SR, Ding H, Standaert DG, Yacoubian TA.

PLoS One. 2013;8(2):e56092. doi: 10.1371/journal.pone.0056092. Epub 2013 Feb 7.

8.

Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.

Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K.

J Neurosci. 2009 Oct 28;29(43):13543-56. doi: 10.1523/JNEUROSCI.4144-09.2009.

9.

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK.

J Neurosci. 2001 Dec 15;21(24):9519-28.

10.

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S.

J Neurochem. 2000 Feb;74(2):721-9.

PMID:
10646524
11.
12.

The mouse MPTP model: gene expression changes in dopaminergic neurons.

Kühn K, Wellen J, Link N, Maskri L, Lübbert H, Stichel CC.

Eur J Neurosci. 2003 Jan;17(1):1-12.

PMID:
12534964
13.

Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.

Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A.

Toxicology. 2014 May 7;319:38-43. doi: 10.1016/j.tox.2014.02.009. Epub 2014 Mar 4.

PMID:
24607817
14.

Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.

Yamada M, Kida K, Amutuhaire W, Ichinose F, Kaneki M.

Biochem Biophys Res Commun. 2010 Nov 12;402(2):312-8. doi: 10.1016/j.bbrc.2010.10.023. Epub 2010 Oct 19.

15.

Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.

Wang J, Duhart HM, Xu Z, Patterson TA, Newport GD, Ali SF.

Neurochem Int. 2008 May;52(6):1037-43. Epub 2007 Nov 4.

PMID:
18069091
16.

Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

Zawada WM, Banninger GP, Thornton J, Marriott B, Cantu D, Rachubinski AL, Das M, Griffin WS, Jones SM.

J Neuroinflammation. 2011 Oct 5;8:129. doi: 10.1186/1742-2094-8-129.

17.

Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

Karunakaran S, Saeed U, Mishra M, Valli RK, Joshi SD, Meka DP, Seth P, Ravindranath V.

J Neurosci. 2008 Nov 19;28(47):12500-9. doi: 10.1523/JNEUROSCI.4511-08.2008.

18.

[Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].

Wang YS, Zhou JP, Wei ZF, Tian QY, Zhou HX, Zhang YX.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1199-202, 1205. Chinese.

19.

Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.

Guo B, Xu D, Duan H, Du J, Zhang Z, Lee SM, Wang Y.

Biol Pharm Bull. 2014;37(2):274-85. Epub 2013 Dec 3.

20.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk